{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:58:23Z","timestamp":1785761903474,"version":"3.56.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:00:00Z","timestamp":1554681600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["AstraZeneca"],"award-info":[{"award-number":["AstraZeneca"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00592-018-01284-4","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T16:35:47Z","timestamp":1554741347000},"page":"889-897","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Diabetes management and treatment approaches outside of North America and West Europe in 2006 and 2015"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3769-9666","authenticated-orcid":false,"given":"Maryam","family":"Tabesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianna J.","family":"Magliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie K.","family":"Tanamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Surmont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silver","family":"Bahendeka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chern-En","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge F.","family":"Elgart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan J.","family":"Gagliardino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satheesh","family":"Krishnamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Luk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Maegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha A.","family":"Motala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fraser","family":"Pirie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambady","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Tayeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Vikulova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jencia","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"key":"1284_CR1","volume-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2017","unstructured":"International Diabetes Federation (2017) IDF Diabetes Atlas, 8th\u00a0edn. International Diabetes Federation, Brussels","edition":"8"},{"issue":"10027","key":"1284_CR2","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","volume":"387","author":"Collaboration NCDRF","year":"2016","unstructured":"Collaboration NCDRF (2016) Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 387(10027):1513\u20131530. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(16)00618-8","journal-title":"Lancet"},{"key":"1284_CR3","volume-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2015","unstructured":"International Diabetes Federation (2015) IDF Diabetes Atlas, 7\u00a0edn. International Diabetes Federation, Brussels","edition":"7"},{"issue":"15","key":"1284_CR4","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359(15):1577\u20131589. \n                    https:\/\/doi.org\/10.1056\/NEJMoa0806470","journal-title":"N Engl J Med"},{"issue":"24","key":"1284_CR5","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","volume":"358","author":"HC Gerstein","year":"2008","unstructured":"Action to Control Cardiovascular Risk in Diabetes Study G, Gerstein HC, Miller ME et al (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358 (24):2545\u20132559. \n                    https:\/\/doi.org\/10.1056\/NEJMoa0802743","journal-title":"N Engl J Med"},{"issue":"4","key":"1284_CR6","doi-asserted-by":"publisher","first-page":"262","DOI":"10.7326\/0003-4819-159-4-201308200-00007","volume":"159","author":"D Vasilakou","year":"2013","unstructured":"Vasilakou D, Karagiannis T, Athanasiadou E et al (2013) Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med 159(4):262\u2013274. \n                    https:\/\/doi.org\/10.7326\/0003-4819-159-4-201308200-00007","journal-title":"Ann Intern Med"},{"issue":"1","key":"1284_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2337\/dc14-2441","volume":"38","author":"SE Inzucchi","year":"2015","unstructured":"Inzucchi SE, Bergenstal RM, Buse JB et al (2015) Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 38(1):140\u2013149. \n                    https:\/\/doi.org\/10.2337\/dc14-2441","journal-title":"Diabetes Care"},{"issue":"11","key":"1284_CR8","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.2337\/dc10-0678","volume":"33","author":"HC Looker","year":"2010","unstructured":"Looker HC, Krakoff J, Andre V et al (2010) Secular trends in treatment and control of type 2 diabetes in an American Indian population: a 30-year longitudinal study. Diabetes Care 33(11):2383\u20132389. \n                    https:\/\/doi.org\/10.2337\/dc10-0678","journal-title":"Diabetes Care"},{"issue":"10","key":"1284_CR9","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1177\/1060028013503624","volume":"47","author":"MA Raebel","year":"2013","unstructured":"Raebel MA, Xu S, Goodrich GK et al (2013) Initial antihyperglycemic drug therapy among 241,327 adults with newly identified diabetes from 2005 through 2010: a surveillance, prevention, and management of diabetes mellitus (SUPREME-DM) study. Ann Pharmacother 47(10):1280\u20131291. \n                    https:\/\/doi.org\/10.1177\/1060028013503624","journal-title":"Ann Pharmacother"},{"key":"1284_CR10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.diabres.2016.06.018","volume":"118","author":"S Liatis","year":"2016","unstructured":"Liatis S, Dafoulas GE, Kani C et al (2016) The prevalence and treatment patterns of diabetes in the Greek population based on real-world data from the nation-wide prescription database. Diabetes Res Clin Pract 118:162\u2013167. \n                    https:\/\/doi.org\/10.1016\/j.diabres.2016.06.018","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"1284_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/dom.12407","volume":"17","author":"P Levin","year":"2015","unstructured":"Levin P, Wei W, Miao R et al (2015) Therapeutically interchangeable? A study of real-world outcomes associated with switching basal insulin analogues among US patients with type 2 diabetes mellitus using electronic medical records data. Diabetes Obes Metab 17(3):245\u2013253. \n                    https:\/\/doi.org\/10.1111\/dom.12407","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"1284_CR12","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1185\/03007995.2014.952716","volume":"30","author":"J Lian","year":"2014","unstructured":"Lian J, Liang Y (2014) Diabetes management in the real world and the impact of adherence to guideline recommendations. Curr Med Res Opin 30(11):2233\u20132240. \n                    https:\/\/doi.org\/10.1185\/03007995.2014.952716","journal-title":"Curr Med Res Opin"},{"issue":"10","key":"1284_CR13","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/pds.1802","volume":"18","author":"KB Filion","year":"2009","unstructured":"Filion KB, Joseph L, Boivin JF, Suissa S, Brophy JM (2009) Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis. Pharmacoepidemiol Drug Saf 18(10):973\u2013976. \n                    https:\/\/doi.org\/10.1002\/pds.1802","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"1284_CR14","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.pcd.2015.03.009","volume":"9","author":"C Torre","year":"2015","unstructured":"Torre C, Guerreiro J, de Oliveira Martins S, Raposo JF, Martins AP, Leufkens H (2015) Patterns of glucose lowering drugs utilization in Portugal and in the Netherlands. Trends over time. Prim Care Diabetes 9(6):482\u2013489. \n                    https:\/\/doi.org\/10.1016\/j.pcd.2015.03.009","journal-title":"Prim Care Diabetes"},{"issue":"41","key":"1284_CR15","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3238\/arztebl.2009.0664","volume":"106","author":"GP Hammer","year":"2009","unstructured":"Hammer GP, du Prel JB, Blettner M (2009) Avoiding bias in observational studies: part 8 in a series of articles on evaluation of scientific publications. Dtsch Arztebl Int 106(41):664\u2013668. \n                    https:\/\/doi.org\/10.3238\/arztebl.2009.0664","journal-title":"Dtsch Arztebl Int"},{"issue":"11","key":"1284_CR16","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.2337\/dc16-1974","volume":"40","author":"SV Edelman","year":"2017","unstructured":"Edelman SV, Polonsky WH (2017) Type 2 diabetes in the real world: the elusive nature of glycemic control. Diabetes Care 40(11):1425\u20131432. \n                    https:\/\/doi.org\/10.2337\/dc16-1974","journal-title":"Diabetes Care"},{"issue":"1","key":"1284_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2337\/dc08-9025","volume":"32","author":"DM Nathan","year":"2009","unstructured":"Nathan DM, Buse JB, Davidson MB et al (2009) Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 32(1):193\u2013203. \n                    https:\/\/doi.org\/10.2337\/dc08-9025","journal-title":"Diabetes Care"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-018-01284-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-018-01284-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-018-01284-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T23:29:39Z","timestamp":1586215779000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-018-01284-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["1284"],"URL":"https:\/\/doi.org\/10.1007\/s00592-018-01284-4","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,8]]},"assertion":[{"value":"14 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was supported by AstraZeneca.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Monash University Human Research Ethics Committee (number 1441), and the Alfred Ethics Committee (number 64\/15) in Australia and in some of the sites, as required by local guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights disclosure"}},{"value":"For this type of study, informed consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}